A Phase II Trial Of The Io102-Io103 Vaccine Plus Pembrolizumab: Preliminary Analysis For First-Line (1L) Treatment Of Non-Small Cell Lung Cancer (Nsclc) And Squamous Cell Carcinoma Of The Head And Neck (Scchn)
IO102-IO103;Pembrolizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase II Trial Of The Io102-Io103 Vaccine Plus Pembrolizumab: Preliminary Analysis For First-Line (1L) Treatment Of Non-Small Cell Lung Cancer (Nsclc) And Squamous Cell Carcinoma Of The Head And Neck (Scchn) ### Output: IO102-IO103;Pembrolizumab